BECONASE AQ Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Beconase Aq, and what generic alternatives are available?
Beconase Aq is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in BECONASE AQ is beclomethasone dipropionate monohydrate. There are twenty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the beclomethasone dipropionate monohydrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BECONASE AQ?
- What are the global sales for BECONASE AQ?
- What is Average Wholesale Price for BECONASE AQ?
Summary for BECONASE AQ
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 65 |
| Clinical Trials: | 4 |
| Patent Applications: | 30 |
| Drug Prices: | Drug price information for BECONASE AQ |
| DailyMed Link: | BECONASE AQ at DailyMed |
Recent Clinical Trials for BECONASE AQ
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| West Penn Allegheny Health System | Phase 4 |
| University Health Network, Toronto | N/A |
| Glaucoma Research Society of Canada | N/A |
Pharmacology for BECONASE AQ
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for BECONASE AQ
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | BECONASE AQ | beclomethasone dipropionate monohydrate | SPRAY, METERED;NASAL | 019389-001 | Jul 27, 1987 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
